Wesche Holger 4
4 · Harpoon Therapeutics, Inc. · Filed Jul 6, 2021
Insider Transaction Report
Form 4
Wesche Holger
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-07-01$0.60/sh+10,000$6,000→ 62,852 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-07-01−10,000→ 21,002 totalExercise: $0.60Exp: 2026-04-06→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-07-01$14.00/sh−10,000$140,000→ 52,852 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The shares subject to the option are fully vested and exercisable.